Open AccessRecent FDA approval of sofosbuvir and simeprevir. Implications for current HCV treatment
Author(s) -
Lin M. Valerie,
Chung Raymond
Publication year - 2014
Publication title -
clinical liver disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 14
ISSN - 2046-2484
DOI - 10.1002/cld.332
Subject(s) - simeprevir , ns5b , virology , sofosbuvir , ns3 , boceprevir , hepatitis c virus , telaprevir , protease , biology , imp dehydrogenase , virus , hepacivirus , enzyme , medicine , biochemistry , ribavirin , surgery , transplantation , mycophenolic acid
Watch a video presentation of this article Answer questions and earn CME